BioImagene Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
50
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$100M
- Investors
-
1
BioImagene General Information
Description
Provider of digital pathology solutions for clinical diagnostics and drug discovery applications. The company develops and distributes integrated hardware and software systems to acquire, view, share, manage, archive, and analyze tissue images in pathology laboratories. It offers IHC algorithms, such as HER2, ER/PR, and p53 for breast cancer; Ki67 for breast, brain, and prostate cancers; CD138 for multiple myeloma; CD3/CD20 for lymphoma; iSlide input device, a device that allows pathologists to use a microscope interface to manipulate digital images of slides; and iScan Coreo Au digital slide scanners that enable digital pathology applications, such as image analysis, telepathology, remote microscopy, and education.
Contact Information
Website
www.bioimagene.comCorporate Office
- 134 South De Anza
- Suite 203
- San Jose, CA 95129
- United States
Corporate Office
- 134 South De Anza
- Suite 203
- San Jose, CA 95129
- United States
BioImagene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 23-Aug-2010 | $100M | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series D1) | 31-Dec-2009 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 16-Oct-2008 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 12-Aug-2008 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B2) | 15-Nov-2004 | Completed | Startup | |||
| 4. Early Stage VC (Series B) | 12-Oct-2004 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B1) | 10-Sep-2004 | Completed | Startup | |||
| 2. Later Stage VC (Series C) | Completed | |||||
| 1. Early Stage VC (Series A) | Completed |
BioImagene Patents
BioImagene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20100225668-A1 | Modes and interfaces for observation, and manipulation of digital images on computer screen in support of pathologist's workflow | Active | 09-Mar-2009 | ||
| DE-60016049-T2 | Method for the objective determination of the severity of scars | Inactive | 15-Jan-1999 | ||
| DE-60016049-D1 | Procedure for the objective determination of the severity of scars | Inactive | 15-Jan-1999 | A61B5/441 |
BioImagene Signals
BioImagene Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Artiman Ventures | Venture Capital | Minority | ||
| Ascension Ventures | Corporate Venture Capital | Minority | ||
| Authosis Ventures | Venture Capital | Minority | ||
| Band of Angels | Angel Group | Minority | ||
| Burrill & Co | Merchant Banking Firm | Minority |
BioImagene Acquisitions (1)
BioImagene’s most recent deal was a Merger/Acquisition with Scimagix. The deal was made on 15-Nov-2004.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Scimagix | 15-Nov-2004 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
BioImagene FAQs
-
When was BioImagene founded?
BioImagene was founded in 2003.
-
Where is BioImagene headquartered?
BioImagene is headquartered in San Jose, CA.
-
What is the size of BioImagene?
BioImagene has 50 total employees.
-
What industry is BioImagene in?
BioImagene’s primary industry is Diagnostic Equipment.
-
Is BioImagene a private or public company?
BioImagene is a Private company.
-
What is the current valuation of BioImagene?
The current valuation of BioImagene is .
-
What is BioImagene’s current revenue?
The current revenue for BioImagene is .
-
How much funding has BioImagene raised over time?
BioImagene has raised $47.2M.
-
Who are BioImagene’s investors?
Artiman Ventures, Ascension Ventures, Authosis Ventures, Band of Angels, and Burrill & Co are 5 of 11 investors who have invested in BioImagene.
-
When was BioImagene acquired?
BioImagene was acquired on 23-Aug-2010.
-
Who acquired BioImagene?
BioImagene was acquired by Ventana Medical Systems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process